SIRPant Immunotherapeutics
SIRPant Immunotherapeutics develops an approach to elicit tumor-specific T-cells through one of two alternative means: in vivo or ex vivo.
SIRPant Immunotherapeutics is a company in biotechnology, medical, therapeutics based in Great Lakes, Northeastern US, founded in 2020.
Its activity falls under biotechnology, medical, therapeutics; the profile below is assembled from public directory data.
Great Lakes, Northeastern US is where the company is located.
It is recorded at the Series_Unknown stage.
The company reports a headcount in the c_00001_00010 range.
It has disclosed roughly $6.2M in funding.
| Sector | Biotechnology, Medical, Therapeutics |
|---|---|
| Headquarters | Great Lakes, Northeastern US |
| Founded | 2020 |
| Employees | c_00001_00010 |
| Stage | series_unknown |
| Total funding | $6,221,031 |
Website: sirpantimmunotx.com
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account